tiprankstipranks
Prometheus Biosciences (RXDX)
NASDAQ:RXDX
US Market

Prometheus Biosciences (RXDX) Technical Analysis

0 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
0Neutral
7Bearish
Technical Analysis Consensus
Strong Sell
2Bullish
0Neutral
6Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Prometheus Biosciences’s (RXDX) Moving Averages Convergence Divergence (MACD) indicator is 1.10, suggesting Prometheus Biosciences is a Buy.
Prometheus Biosciences’s (RXDX) 20-Day exponential moving average is 199.52, while Prometheus Biosciences’s (RXDX) share price is $199.92, making it a Buy.
Prometheus Biosciences’s (RXDX) 50-Day exponential moving average is 191.71, while Prometheus Biosciences’s (RXDX) share price is $199.92, making it a Buy.

Prometheus Biosciences (RXDX) Pivot Points

Apr 28, 2024, 11:40 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
199.31
199.45
199.69
199.83
200.07
200.21
200.45
Fibonacci
199.45
199.60
199.69
199.83
199.98
200.07
200.21
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Prometheus Biosciences (RXDX) Moving Averages

Apr 28, 2024, 11:40 AM
Period
Simple
Exponential
MA5
199.92Sell
199.92Buy
MA10
199.92Buy
199.90Buy
MA20
199.92Buy
199.52Buy
MA50
197.95Buy
191.71Buy
MA100
166.79Buy
170.88Buy
MA200
124.11Buy
130.02Buy
Prometheus Biosciences’s (RXDX) 10-Day exponential moving average is 199.90, while Prometheus Biosciences’s (RXDX) share price is $199.92, making it a Buy.
Prometheus Biosciences’s (RXDX) 100-Day exponential moving average is 170.88, while Prometheus Biosciences’s (RXDX) share price is $199.92, making it a Buy.
Prometheus Biosciences’s (RXDX) stock price is $199.92 and Prometheus Biosciences’s (RXDX) 50-day simple moving average is 197.95, creating a Buy signal.
Prometheus Biosciences’s (RXDX) stock price is $199.92 and Prometheus Biosciences’s (RXDX) 100-day simple moving average is 166.79, creating a Buy signal.
Prometheus Biosciences’s (RXDX) stock price is $199.92 and Prometheus Biosciences’s (RXDX) 200-day simple moving average is 124.11, creating a Buy signal.

Prometheus Biosciences (RXDX) Technical Indicators

Apr 28, 2024, 11:40 AM
Name
Value
Implied Action
RSI (14)
84.04
Sell
STOCH (9,6)
84.21
Sell
STOCHRSI (14)
84.21
Sell
MACD (12,26)
1.10
Buy
ADX (14)
60.00
Sell
Williams %R
-15.79
Sell
CCI (14)
0.00
-
ATR (14)
0.53
-
Ultimate Oscillator
83.40
Buy
ROC
0.00
-
Prometheus Biosciences’s (RXDX) Relative Strength Index (RSI) is 84.04, creating a Sell signal.
Prometheus Biosciences’s (RXDX) Trend Strength Indicator (ADX) is 60.00, creating a Sell signal.

FAQ

Is RXDX a Buy, Hold, or Sell?
Based on RXDX’s technical indicators, RXDX is a Buy.
    What is RXDX’s RSI (14)?
    RXDX’s RSI (14) is 84.04, which suggests RXDX is a Sell.
      What is RXDX’s MACD?
      RXDX’s MACD is 1.10, which suggests RXDX is a Buy.
        What is RXDX’s 5-day moving average?
        RXDX’s 5-day moving average is 199.92, which suggests RXDX is a Sell.
          What is RXDX’s 20-day moving average?
          RXDX 20-day moving average is 199.92, which suggests RXDX is a Buy.
            What is RXDX’s 50-day moving average?
            RXDX’s 50-day moving average is 197.95, which suggests RXDX is a Buy.
              What is RXDX’s 200-day moving average?
              RXDX’s 200-day moving average is 124.11, which suggests RXDX is a Buy.
                What is RXDX’s Williams % R (14)?
                RXDX’s Williams % R (14) is -15.79, which suggests RXDX is a Sell.
                  What is RXDX’s CCI (14)?
                  Currently, no data Available
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis